34 related articles for article (PubMed ID: 1909969)
1. The repeated administration of rhIL-12 for 14 weeks in rhesus monkeys: A toxicity assessment.
Ding H; Qin H; Wang J; Dong Y; Wang Q; Han Y
J Appl Toxicol; 2024 Feb; 44(2):301-312. PubMed ID: 37770382
[TBL] [Abstract][Full Text] [Related]
2. Personalized Medicine Using Neuroimmunological Biomarkers in Depressive Disorders.
Chi S; Lee MS
J Pers Med; 2021 Feb; 11(2):. PubMed ID: 33578686
[TBL] [Abstract][Full Text] [Related]
3. Transcriptional and Bioinformatic Analysis Provide a Relationship between Host Response Changes to Marek's Disease Viruses Infection and an Integrated Long Terminal Repeat.
Cui N; Li X; Chen C; Hao H; Su S; Cui Z
Front Cell Infect Microbiol; 2016; 6():46. PubMed ID: 27200301
[TBL] [Abstract][Full Text] [Related]
4. The inflammation hypothesis in geriatric depression.
Alexopoulos GS; Morimoto SS
Int J Geriatr Psychiatry; 2011 Nov; 26(11):1109-18. PubMed ID: 21370276
[TBL] [Abstract][Full Text] [Related]
5. Effects of the anti-interleukin-6 receptor antibody, tocilizumab, on serum lipid levels in patients with rheumatoid arthritis.
Kawashiri SY; Kawakami A; Yamasaki S; Imazato T; Iwamoto N; Fujikawa K; Aramaki T; Tamai M; Nakamura H; Ida H; Origuchi T; Ueki Y; Eguchi K
Rheumatol Int; 2011 Apr; 31(4):451-6. PubMed ID: 20024554
[TBL] [Abstract][Full Text] [Related]
6. Potential role of interleukin 6 in reactive thrombocytosis and acute phase response in pulmonary tuberculosis.
Unsal E; Aksaray S; Köksal D; Sipit T
Postgrad Med J; 2005 Sep; 81(959):604-7. PubMed ID: 16143693
[TBL] [Abstract][Full Text] [Related]
7. Interleukin-6 is necessary, but not sufficient, for induction of the humanC-reactive protein gene in vivo.
Weinhold B; Bader A; Poli V; Rüther U
Biochem J; 1997 Aug; 325 ( Pt 3)(Pt 3):617-21. PubMed ID: 9271080
[TBL] [Abstract][Full Text] [Related]
8. The relationship between weight loss and interleukin 6 in non-small-cell lung cancer.
Scott HR; McMillan DC; Crilly A; McArdle CS; Milroy R
Br J Cancer; 1996 Jun; 73(12):1560-2. PubMed ID: 8664130
[TBL] [Abstract][Full Text] [Related]
9. Immune function of patients receiving recombinant human interleukin-6 (IL-6) in a phase I clinical study: induction of C-reactive protein and IgE and inhibition of natural killer and lymphokine-activated killer cell activity.
Scheid C; Young R; McDermott R; Fitzsimmons L; Scarffe JH; Stern PL
Cancer Immunol Immunother; 1994 Feb; 38(2):119-26. PubMed ID: 8306367
[TBL] [Abstract][Full Text] [Related]
10. Prediction of the role of granulocyte-macrophage colony-stimulating factor in animals and man from in vitro results.
Liehl E; Hildebrandt J; Lam C; Mayer P
Eur J Clin Microbiol Infect Dis; 1994; 13 Suppl 2():S9-17. PubMed ID: 7875154
[TBL] [Abstract][Full Text] [Related]
11. Proliferative response of human marrow myeloid progenitor cells to in vivo treatment with granulocyte colony-stimulating factor alone and in combination with interleukin-3 after autologous bone marrow transplantation.
Lemoli RM; Fortuna A; Fogli M; Gherlinzoni F; Rosti G; Catani L; Gozzetti A; Miggiano MC; Tura S
Exp Hematol; 1995 Dec; 23(14):1520-6. PubMed ID: 8542941
[TBL] [Abstract][Full Text] [Related]
12. Adjuvant therapy with recombinant interleukin-3 and granulocyte-macrophage colony-stimulating factor.
Schulz G; Krumwieh D; Oster W
Pharmacol Ther; 1991 Oct; 52(1):85-94. PubMed ID: 1805248
[TBL] [Abstract][Full Text] [Related]
13. Preclinical pharmacologic basis for clinical use of rhIL-11 as an effective platelet-support agent.
Berl T; Schwertschlag U
Oncology (Williston Park); 2000 Sep; 14(9 Suppl 8):12-20. PubMed ID: 11033834
[TBL] [Abstract][Full Text] [Related]
14. Recombinant human interleukin 6 is a potent inducer of the acute phase response and elevates the blood platelets in nonhuman primates.
Mayer P; Geissler K; Valent P; Ceska M; Bettelheim P; Liehl E
Exp Hematol; 1991 Aug; 19(7):688-96. PubMed ID: 1909969
[TBL] [Abstract][Full Text] [Related]
15. Effects of recombinant human granulocyte-macrophage colony-stimulating factor on platelet survival and activation using a nonhuman primate model.
Tomer A; Stahl CP; McClure HM; Anderson DC; Myers LA; Liehl E; Winton EF
Exp Hematol; 1993 Nov; 21(12):1577-82. PubMed ID: 8405239
[TBL] [Abstract][Full Text] [Related]
16. In vitro and in vivo activity of human recombinant granulocyte-macrophage colony-stimulating factor in dogs.
Mayer P; Werner FJ; Lam C; Besemer J
Exp Hematol; 1990 Oct; 18(9):1026-33. PubMed ID: 2168838
[TBL] [Abstract][Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
